We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+9.19%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$9.7B
AUM Growth
-$509M
Cap. Flow
-$1.32B
Cap. Flow %
-13.61%
Top 10 Hldgs %
72.63%
Holding
96
New
4
Increased
31
Reduced
29
Closed
10

Top Buys

Rank Stock Value
1
TCOM icon
Trip.com Group
TCOM
+$27.9M
2
HDB icon
HDFC Bank
HDB
+$15.7M
3
OSH
Oak Street Health, Inc.
OSH
+$13.6M
4
TRU icon
TransUnion
TRU
+$6.8M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.96M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$175M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$144M
3
V icon
Visa
V
+$142M
4
TMO icon
Thermo Fisher Scientific
TMO
+$141M
5
FRC
First Republic Bank
FRC
+$97.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.53%
2 Financials 19.45%
3 Healthcare 15.53%
4 Technology 12.74%
5 Communication Services 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNC icon
26
Centene
CNC
$31.2B
$30.2M 0.31%
414,756
– –
ILMN icon
27
Illumina
ILMN
$29.2B
$27.4M 0.28%
59,601
– –
NVCR icon
28
NovoCure
NVCR
$1.81B
$24.8M 0.26%
111,784
-15,000
-12% -$2.92M
BHVN
29
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$24M 0.25%
247,498
– –
TFX icon
30
Teleflex
TFX
$5.85B
$23.3M 0.24%
58,000
– –
LHCG
31
DELISTED
LHC Group LLC
LHCG
$22.2M 0.23%
110,657
– –
VRTX icon
32
Vertex Pharmaceuticals
VRTX
$124B
$21.9M 0.23%
108,557
– –
QDEL icon
33
QuidelOrtho
QDEL
$1.13B
$20.5M 0.21%
160,000
– –
ALGN icon
34
Align Technology
ALGN
$12.9B
$20.4M 0.21%
33,428
+5,000
+18% +$2.96M
AXNX
35
DELISTED
Axonics, Inc. Common Stock
AXNX
$20.3M 0.21%
320,000
-80,000
-20% -$4.72M
PODD icon
36
Insulet
PODD
$11.7B
$20M 0.21%
72,908
– –
TDOC icon
37
Teladoc Health
TDOC
$1.69B
$19.1M 0.2%
115,000
+20,000
+21% +$3.24M
HRTX icon
38
Heron Therapeutics
HRTX
$93.7M
$18.7M 0.19%
1,202,069
– –
AERI
39
DELISTED
Aerie Pharmaceuticals
AERI
$18.5M 0.19%
1,156,142
– –
BMRN icon
40
BioMarin Pharmaceuticals
BMRN
$12B
$17.8M 0.18%
213,851
+50,000
+31% +$3.96M
GKOS icon
41
Glaukos
GKOS
$9.18B
$16.7M 0.17%
197,212
– –
CHRS icon
42
Coherus Oncology
CHRS
$222M
$14.6M 0.15%
1,058,464
– –
INFY icon
43
Infosys
INFY
$50.6B
$14M 0.14%
659,783
+107,880
+20% +$2.06M
OSH
44
DELISTED
Oak Street Health, Inc.
OSH
$13.3M 0.14%
+227,933
New +$13.6M
KRYS icon
45
Krystal Biotech
KRYS
$10.6B
$12.6M 0.13%
185,809
– –
KPTI icon
46
Karyopharm Therapeutics
KPTI
$155M
$12.4M 0.13%
80,000
– –
INSM icon
47
Insmed
INSM
$22.7B
$9.77M 0.1%
343,110
– –
SRPT icon
48
Sarepta Therapeutics
SRPT
$1.62B
$9.35M 0.1%
120,329
– –
TVRD
49
Tvardi Therapeutics
TVRD
$22.5M
$8.33M 0.09%
16,207
-3,334
-17% -$2.11M
VCRA
50
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$7.57M 0.08%
190,058
– –
1
2
3 4

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2021 Portfolio in Review

As of Q2 2021, C WorldWide Group held 96 positions worth $9.7B, down 5% from $10.2B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

C WorldWide Group withdrew a net $1.32B in Q2 2021, closing 10 positions and reducing 29 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $60.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, C WorldWide Group opened a new position in Oak Street Health, Inc. worth $13.3M.

  • C WorldWide Group's largest Q2 2021 buy was Oak Street Health, Inc.: 227,933 shares worth $13.3M.
  • C WorldWide Group added most to Trip.com Group in Q2 2021, an estimated $27.9M increase.
  • C WorldWide Group's biggest Q2 2021 reduction was Microsoft, cutting an estimated $175M.
  • C WorldWide Group fully exited IHS Markit Ltd. Common Shares in Q2 2021, selling an estimated $60.6M.
  • C WorldWide Group's ten largest holdings make up 73% of its $9.7B portfolio in Q2 2021.
  • C WorldWide Group opened 4 new positions and closed 10 in Q2 2021.
  • C WorldWide Group's portfolio value fell 5% quarter-over-quarter to $9.7B.

Based on C WorldWide Group's 13F filing for Q2 2021, filed 4 Aug 2021.